TXG
10x Genomics, Inc. Class A Common StockstockNASDAQ
Market OpenNov 17, 2026 10:40:24 AM EST
53.44USD-2.819%(-1.55)393,958
Pre-marketNov 17, 2026 8:10:30 AM EST
55.24USD+0.455%(+0.25)
TXG Financials
In Q3 FY 2026 (ended ), 10x Genomics, Inc. Class A Common Stock (TXG) reported revenue of $150.67M, net income of −$19.43M, operating cash flow of $15.83M, and assets of $1.06B (filed ).
Loading financial statements…